Cholesterol is Inefficiently Converted to Cholesteryl Esters in the Blood of Cardiovascular Disease Patients

[1]  C. Ferreira,et al.  An Integrative Proteomic/Lipidomic Analysis of the Gold Nanoparticle Biocorona in Healthy and Obese Conditions. , 2019, Applied in vitro toxicology.

[2]  M. Delgado-Rodríguez,et al.  Systematic review and meta-analysis. , 2017, Medicina intensiva.

[3]  M. Dobiášová.  Atherogenic impact of lecithin-cholesterol acyltransferase and its relation to cholesterol esterification rate in HDL (FER(HDL)) and AIP [log(TG/HDL-C)] biomarkers: the butterfly effect? , 2017, Physiological research.

[4]  L. Estronca,et al.  Cholesteryl hemiesters alter lysosome structure and function and induce proinflammatory cytokine production in macrophages. , 2017, Biochimica et biophysica acta. Molecular and cell biology of lipids.

[5]  Brian A Ference,et al.  Association Between Lowering LDL-C and Cardiovascular Risk Reduction Among Different Therapeutic Interventions: A Systematic Review and Meta-analysis. , 2016, JAMA.

[6]  G. Franceschini,et al.  Role of LCAT in Atherosclerosis. , 2016, Journal of atherosclerosis and thrombosis.

[7]  M. A. Surma,et al.  An automated shotgun lipidomics platform for high throughput, comprehensive, and quantitative analysis of blood plasma intact lipids , 2015, European journal of lipid science and technology : EJLST.

[8]  D. Rader,et al.  Association of HDL cholesterol efflux capacity with incident coronary heart disease events: a prospective case-control study , 2015, The lancet. Diabetes & endocrinology.

[9]  Alan Bridge,et al.  The SwissLipids knowledgebase for lipid biology , 2015, Bioinform..

[10]  D. Rader,et al.  HDL and cardiovascular disease , 2014, The Lancet.

[11]  A. Kontush.  HDL-mediated mechanisms of protection in cardiovascular disease. , 2014, Cardiovascular research.

[12]  A. Salvador,et al.  Homeostasis of free cholesterol in the blood: a preliminary evaluation and modeling of its passive transport[S] , 2014, Journal of Lipid Research.

[13]  P. Barter,et al.  Cardioprotective functions of HDLs1 , 2014, Journal of Lipid Research.

[14]  Yucheng Chen,et al.  The Value and Distribution of High-Density Lipoprotein Subclass in Patients with Acute Coronary Syndrome , 2014, PloS one.

[15]  A. von Eckardstein,et al.  High-density lipoprotein: vascular protective effects, dysfunction, and potential as therapeutic target. , 2014, Circulation research.

[16]  P. Barter,et al.  Regulation of High-Density Lipoprotein Metabolism , 2014, Circulation research.

[17]  R Core Team,et al.  R: A language and environment for statistical computing. , 2014 .

[18]  A. Shevchenko,et al.  Plasma Lipid Composition and Risk of Developing Cardiovascular Disease , 2013, PloS one.

[19]  J. Kastelein,et al.  Genetics of HDL-C: A Causal Link to Atherosclerosis? , 2013, Current Atherosclerosis Reports.

[20]  J. Heinecke,et al.  The not-so-simple HDL story: A new era for quantifying HDL and cardiovascular risk? , 2012, Nature Medicine.

[21]  M. Van Eck,et al.  Lecithin:cholesterol acyltransferase: old friend or foe in atherosclerosis? , 2012, Journal of Lipid Research.

[22]  A. Shevchenko,et al.  Molecular Etiology of Atherogenesis – In Vitro Induction of Lipidosis in Macrophages with a New LDL Model , 2012, PloS one.

[23]  D. Ng.  The role of lecithin:cholesterol acyltransferase in the modulation of cardiometabolic risks - a clinical update and emerging insights from animal models. , 2012, Biochimica et biophysica acta.

[24]  Michael Schroeder,et al.  LipidXplorer: A Software for Consensual Cross-Platform Lipidomics , 2012, PloS one.

[25]  Robert L Wilensky,et al.  Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis. , 2011, The New England journal of medicine.

[26]  P. Toth.  Cholesterol Efflux Capacity, High-Density Lipoprotein Function, and Atherosclerosis , 2011 .

[27]  Stefan R Bornstein,et al.  A novel informatics concept for high-throughput shotgun lipidomics based on the molecular fragmentation query language , 2011, Genome Biology.

[28]  Eoin Fahy,et al.  Lipidomics reveals a remarkable diversity of lipids in human plasma1[S] , 2010, Journal of Lipid Research.

[29]  A. Balmforth,et al.  Change in serum lipids after acute coronary syndromes: secondary analysis of SPACE ROCKET study data and a comparative literature review. , 2010, Clinical chemistry.

[30]  Pedro M. Valero-Mora,et al.  ggplot2: Elegant Graphics for Data Analysis , 2010 .

[31]  M. Phillips,et al.  High-density lipoprotein heterogeneity and function in reverse cholesterol transport , 2010, Current opinion in lipidology.

[32]  N. Wareham,et al.  Plasma levels of lecithin:cholesterol acyltransferase and risk of future coronary artery disease in apparently healthy men and women: a prospective case-control analysis nested in the EPIC-Norfolk population study , 2010, Journal of Lipid Research.

[33]  B. Asztalos.  High Density Lipoprotein Particles , 2010 .

[34]  Hadley Wickham,et al.  ggplot2 - Elegant Graphics for Data Analysis (2nd Edition) , 2017 .

[35]  J. Iqbal,et al.  Intestinal lipid absorption. , 2009, American journal of physiology. Endocrinology and metabolism.

[36]  Max Kuhn,et al.  Building Predictive Models in R Using the caret Package , 2008 .

[37]  J. Loscalzo,et al.  Lipid levels after acute coronary syndromes. , 2008, Journal of the American College of Cardiology.

[38]  Christina Lindahl,et al.  High-density lipoprotein cholesterol, high-density lipoprotein particle size, and apolipoprotein A-I: significance for cardiovascular risk: the IDEAL and EPIC-Norfolk studies. , 2008, Journal of the American College of Cardiology.

[39]  D. Vance,et al.  Phospholipid biosynthesis in eukaryotes , 2008 .

[40]  L. Estronca,et al.  Kinetics and thermodynamics of the association of dehydroergosterol with lipid bilayer membranes. , 2007, Biophysical journal.

[41]  G. Franceschini,et al.  The Molecular Basis of Lecithin:Cholesterol Acyltransferase Deficiency Syndromes: A Comprehensive Study of Molecular and Biochemical Findings in 13 Unrelated Italian Families , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[42]  J. Sampaio,et al.  Kinetics and thermodynamics of association of a fluorescent lysophospholipid derivative with lipid bilayers in liquid-ordered and liquid-disordered phases. , 2005, Biophysical journal.

[43]  J. Laranjinha,et al.  Kinetics and thermodynamics of lipid amphiphile exchange between lipoproteins and albumin in serum. , 2005, Biophysical journal.

[44]  L. Cupples,et al.  High-Density Lipoprotein Subpopulation Profile and Coronary Heart Disease Prevalence in Male Participants of the Framingham Offspring Study , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[45]  C. Fielding,et al.  Molecular mechanism of reverse cholesterol transport: reaction of pre-beta-migrating high-density lipoprotein with plasma lecithin/cholesterol acyltransferase. , 2004, Biochemistry.

[46]  M. J. Moreno,et al.  Kinetics and thermodynamics of association of a phospholipid derivative with lipid bilayers in liquid-disordered and liquid-ordered phases. , 2004, Biophysical journal.

[47]  Christer S. Ejsing,et al.  Charting molecular composition of phosphatidylcholines by fatty acid scanning and ion trap MS3 fragmentation Published, JLR Papers in Press, August 16, 2003. DOI 10.1194/jlr.D300020-JLR200 , 2003, Journal of Lipid Research.

[48]  P. Shannon,et al.  Cytoscape: a software environment for integrated models of biomolecular interaction networks. , 2003, Genome research.

[49]  S. Hazen,et al.  A Novel Family of Atherogenic Oxidized Phospholipids Promotes Macrophage Foam Cell Formation via the Scavenger Receptor CD36 and Is Enriched in Atherosclerotic Lesions* , 2002, Journal of Biological Chemistry.

[50]  E. Fisher,et al.  Complexity in the Secretory Pathway: The Assembly and Secretion of Apolipoprotein B-containing Lipoproteins* , 2002, The Journal of Biological Chemistry.

[51]  G. S. Shelness,et al.  Very-low-density lipoprotein assembly and secretion , 2001, Current opinion in lipidology.

[52]  J. Borén,et al.  The assembly and secretion of apolipoprotein B-containing lipoproteins. , 1999, Current opinion in lipidology.

[53]  N. Moatti,et al.  Inhibition of lecithin cholesterol acyltransferase by phosphatidylcholine hydroperoxides , 1999, FEBS letters.

[54]  G. Feigenson,et al.  Maximum solubility of cholesterol in phosphatidylcholine and phosphatidylethanolamine bilayers. , 1999, Biochimica et biophysica acta.

[55]  M. Liu,et al.  Modulation of the positional specificity of lecithin-cholesterol acyltransferase by the acyl group composition of its phosphatidylcholine substrate: role of the sn-1-acyl group. , 1998, Biochemistry.

[56]  G. Assmann,et al.  The molecular pathology of lecithin:cholesterol acyltransferase (LCAT) deficiency syndromes. , 1997, Journal of lipid research.

[57]  M. Liu,et al.  Role of sn-2 acyl group of phosphatidylcholine in determining the positional specificity of lecithin-cholesterol acyltransferase. , 1994, Biochemistry.

[58]  B. G. Brown,et al.  Altered particle size distribution of apolipoprotein A-I-containing lipoproteins in subjects with coronary artery disease. , 1991, Journal of lipid research.